Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
13F holders, Q4 2023
Institutional positions in Calidi Biotherapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −4 vs. Q3 2023
- Shares held
- 5.63M
- −544.1K (−8.8%) vs. Q3 2023
- Total value
- $384.0K
- −$1.26M (−76.6%) vs. Q3 2023
- New holders
- 0
- 1 more added
- Sold out
- 4
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $1.01K |
| Q3 2024 | 16 | $99.4K |
| Q2 2024 | 17 | $281.5K |
| Q1 2024 | 17 | $385.1K |
| Q4 2023 | 18 | $384.0K |
| Q3 2023 | 22 | $1.64M |
| Q2 2023 | 22 | $866.3K |
| Q1 2023 | 24 | $366.1K |
| Q4 2022 | 25 | $350.0K |
| Q3 2022 | 27 | $479.9K |
| Q2 2022 | 28 | $767.0K |
| Q1 2022 | 29 | $2.83M |
| Q4 2021 | 23 | $3.01M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,165,086 | $139.6K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $81.4K | 0.00% | – | – |
| Finepoint Capital LP | 655,200 | $32.8K | 0.01% | 00.0% | Unchanged |
| Aristeia Capital LLC | 494,400 | $31.9K | 0.00% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 600,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 450,000 | $22.5K | 0.00% | −200,000−30.8% | Reduced |
| Arena Investors LP | 333,333 | $21.5K | 0.14% | 00.0% | Unchanged |
| Cowen and Company, LLC | 172,236 | $8.61K | 0.00% | +72,236+72.2% | Added |
| EHP Funds Inc. | 107,964 | $6.96K | 0.00% | −79,950−42.5% | Reduced |
| Exos TFP Holdings LLC | 105,000 | $5.25K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 36,469 | $1.82K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 20,052 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 5,229 | $261 | 0.00% | −60,882−92.1% | Reduced |
| Sea Otter Advisors LLC | 4,871 | $244 | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 1,746 | $87 | 0.00% | −200−10.3% | Reduced |
| The PNC Financial Services Group, Inc. | 50 | $2 | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 467,818 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 12,500 | – | – | 00.0% | Unchanged |
| Periscope Capital Inc. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Ionic Capital Management LLC | 0 | $0 | 0.00% | −75,172−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |